{"id":"https://openalex.org/W2187420183","doi":null,"title":"Continuous therapy with lenalidomide in multiple myeloma","display_name":"Continuous therapy with lenalidomide in multiple myeloma","publication_year":2013,"publication_date":"2013-01-01","ids":{"openalex":"https://openalex.org/W2187420183","mag":"2187420183"},"language":"en","primary_location":{"id":"mag:2187420183","doi":null,"is_oa":false,"landing_page_url":"http://www.oncologyex.com/pdf/vol12_no1/review_lenalidomide-multiplemyeloma.pdf","pdf_url":null,"source":null,"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null},"volume":null,"type":"article","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5065238694","display_name":"Nizar Jacques Bahlis","orcid":"https://orcid.org/0000-0001-7353-7034","observed_orcids":["https://orcid.org/0000-0001-7353-7034"]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Nizar J. Bahlis","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-7353-7034","affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":["https://openalex.org/A5065238694"],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10649","display_name":"Multiple Myeloma Research and Treatments","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10649","display_name":"Multiple Myeloma Research and Treatments","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12534","display_name":"Protein Degradation and Inhibitors","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11221","display_name":"Bone health and treatments","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/lenalidomide","display_name":"lenalidomide","score":0.9789999723434448},{"id":"https://openalex.org/keywords/multiple-myeloma","display_name":"multiple myeloma","score":0.9700000286102295},{"id":"https://openalex.org/keywords/continuous-treatment","display_name":"continuous treatment","score":0.7210000157356262},{"id":"https://openalex.org/keywords/maintenance-therapy","display_name":"maintenance therapy","score":0.9240000247955322},{"id":"https://openalex.org/keywords/residual-disease","display_name":"residual disease","score":0.7749999761581421},{"id":"https://openalex.org/keywords/transplant-ineligible-patients","display_name":"transplant-ineligible patients","score":0.6930000185966492},{"id":"https://openalex.org/keywords/transplant-eligible-patients","display_name":"transplant-eligible patients","score":0.8949999809265137},{"id":"https://openalex.org/keywords/second-primary-malignancy","display_name":"second primary malignancy","score":0.9819999933242798},{"id":"https://openalex.org/keywords/event-free-survival","display_name":"event-free survival","score":0.9509999752044678},{"id":"https://openalex.org/keywords/clonal-plasma-cells","display_name":"clonal plasma cells","score":0.640999972820282}],"concepts":[{"id":"https://openalex.org/C2776063141","wikidata":"https://www.wikidata.org/wiki/Q425681","display_name":"Lenalidomide","level":3,"score":0.9634015560150146},{"id":"https://openalex.org/C2776364478","wikidata":"https://www.wikidata.org/wiki/Q467635","display_name":"Multiple myeloma","level":2,"score":0.8240948915481567},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7044388055801392},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5719888806343079},{"id":"https://openalex.org/C2778283404","wikidata":"https://www.wikidata.org/wiki/Q6736822","display_name":"Maintenance therapy","level":3,"score":0.566435694694519},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5370069742202759},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.47264403104782104},{"id":"https://openalex.org/C2779823535","wikidata":"https://www.wikidata.org/wiki/Q6865356","display_name":"Minimal residual disease","level":3,"score":0.45674198865890503},{"id":"https://openalex.org/C2991767035","wikidata":"https://www.wikidata.org/wiki/Q179661","display_name":"Induction therapy","level":3,"score":0.43946754932403564},{"id":"https://openalex.org/C3019894029","wikidata":"https://www.wikidata.org/wiki/Q332823","display_name":"Overall survival","level":2,"score":0.42103099822998047},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.36468321084976196},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.18193429708480835},{"id":"https://openalex.org/C2780007613","wikidata":"https://www.wikidata.org/wiki/Q546523","display_name":"Bone marrow","level":2,"score":0.13337373733520508},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.10049322247505188},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.07816207408905029}],"mesh":[],"locations_count":1,"locations":[{"id":"mag:2187420183","doi":null,"is_oa":false,"landing_page_url":"http://www.oncologyex.com/pdf/vol12_no1/review_lenalidomide-multiplemyeloma.pdf","pdf_url":null,"source":null,"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9763000011444092}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":28,"referenced_works":["https://openalex.org/W1747565189","https://openalex.org/W1974656498","https://openalex.org/W1977194024","https://openalex.org/W1982055936","https://openalex.org/W1985021407","https://openalex.org/W2003426156","https://openalex.org/W2003734726","https://openalex.org/W2004136640","https://openalex.org/W2006680755","https://openalex.org/W2018729528","https://openalex.org/W2038477042","https://openalex.org/W2043590047","https://openalex.org/W2051165614","https://openalex.org/W2055662838","https://openalex.org/W2066800926","https://openalex.org/W2088765731","https://openalex.org/W2102406553","https://openalex.org/W2114217833","https://openalex.org/W2114396320","https://openalex.org/W2120780398","https://openalex.org/W2123214410","https://openalex.org/W2125721471","https://openalex.org/W2128084036","https://openalex.org/W2134902298","https://openalex.org/W2142368474","https://openalex.org/W2171626043","https://openalex.org/W2589439126","https://openalex.org/W2744601260"],"related_works":["https://openalex.org/W2014558226","https://openalex.org/W2941234932","https://openalex.org/W2946983618","https://openalex.org/W7168336869","https://openalex.org/W2190306783","https://openalex.org/W2605270513","https://openalex.org/W2004660757","https://openalex.org/W4256097662","https://openalex.org/W2905407802","https://openalex.org/W2979556847"],"abstract_inverted_index":{"In":[0],"multiple":[1,126],"myeloma,":[2],"the":[3,49,84,96,106,123],"depth":[4],"and":[5,37,69],"maintenance":[6],"of":[7,21,53,86,98,108,125],"response":[8,36],"to":[9,14],"therapy":[10,26,57,115],"has":[11],"been":[12],"shown":[13],"correlate":[15],"with":[16,58,73,76,116],"improved":[17,65],"survival.":[18],"Therefore,":[19],"treatment":[20],"residual":[22,29],"disease":[23,100],"after":[24],"induction":[25],"may":[27],"eradicate":[28],"clonal":[30],"plasma":[31],"cells,":[32],"sustain":[33],"and/or":[34],"deepen":[35],"yield":[38],"better":[39],"outcomes.":[40],"This":[41],"article":[42],"reviews":[43],"3":[44],"recent":[45],"trials":[46,62],"published":[47],"in":[48,83,91],"New":[50],"England":[51],"Journal":[52],"Medicine":[54],"investigating":[55],"continuous":[56,114],"lenalidomide.":[59],"1-3":[60],"These":[61],"each":[63],"demonstrated":[64],"outcomes":[66],"for":[67,122],"transplanteligible":[68],"-ineligible":[70],"patients":[71],"treated":[72],"lenalidomide":[74,117],"compared":[75],"placebo.":[77],"While":[78],"there":[79],"was":[80],"an":[81,92],"increase":[82],"rate":[85],"second":[87],"primary":[88],"malignancies":[89],"(SPM),":[90],"event-free":[93],"survival":[94],"analysis,":[95],"risk":[97,107],"progressive":[99],"or":[101],"death":[102],"from":[103],"myeloma":[104,127],"outweighed":[105],"SPM.":[109],"Based":[110],"on":[111],"these":[112],"data,":[113],"represents":[118],"a":[119],"new":[120],"paradigm":[121],"management":[124],"patients.":[128]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}